136 related articles for article (PubMed ID: 29259449)
1. Analyzing the risk factors for a diminished oocyte retrieval rate under controlled ovarian stimulation.
Nakamura M; Yamashita Y; Hayashi A; Saito N; Yu M; Hayashi M; Terai Y; Ohmichi M
Reprod Med Biol; 2017 Jan; 16(1):40-44. PubMed ID: 29259449
[TBL] [Abstract][Full Text] [Related]
2. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
3. The prevention of ovarian hyperstimulation syndrome.
Corbett S; Shmorgun D; Claman P; ;
J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for oocyte retrieval failure in controlled ovarian hyperstimulation protocols: a retrospective observational cohort study.
Hasegawa A; Takahashi T; Igarashi H; Amita M; Matsukawa J; Nagase S
Reprod Biol Endocrinol; 2015 Jun; 13():53. PubMed ID: 26033112
[TBL] [Abstract][Full Text] [Related]
5. Intrauterine administration of hCG immediately after oocyte retrieval and the outcome of ICSI: a randomized controlled trial.
Navali N; Gassemzadeh A; Farzadi L; Abdollahi S; Nouri M; Hamdi K; Mallah F; Jalilvand F
Hum Reprod; 2016 Nov; 31(11):2520-2526. PubMed ID: 27680029
[TBL] [Abstract][Full Text] [Related]
6. Avoidance of oocyte retrieval on the weekend through the use of scheduled ovarian hyperstimulation for in vitro fertilization and embryo transfer.
Nakagawa K; Yamano S; Senuma M; Myogo K; Yamazaki J; Aono T
Fertil Steril; 1997 Nov; 68(5):787-90. PubMed ID: 9389803
[TBL] [Abstract][Full Text] [Related]
7. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
[TBL] [Abstract][Full Text] [Related]
8. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
[TBL] [Abstract][Full Text] [Related]
9. Women with advanced-stage endometriosis and previous surgery respond less well to gonadotropin stimulation, but have similar IVF implantation and delivery rates compared with women with tubal factor infertility.
Matalliotakis IM; Cakmak H; Mahutte N; Fragouli Y; Arici A; Sakkas D
Fertil Steril; 2007 Dec; 88(6):1568-72. PubMed ID: 17349642
[TBL] [Abstract][Full Text] [Related]
10. Natural cycle IVF in unexplained, endometriosis-associated and tubal factor infertility.
Omland AK; Fedorcsák P; Storeng R; Dale PO; Abyholm T; Tanbo T
Hum Reprod; 2001 Dec; 16(12):2587-92. PubMed ID: 11726579
[TBL] [Abstract][Full Text] [Related]
11. Influence of severe endometriosis on gene expression of vascular endothelial growth factor and interleukin-6 in granulosa cells from patients undergoing controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer.
Yamashita Y; Ueda M; Takehara M; Yamashita H; Suzuki Y; Hung YC; Terai Y; Ueki M
Fertil Steril; 2002 Oct; 78(4):865-71. PubMed ID: 12372470
[TBL] [Abstract][Full Text] [Related]
12. Live birth rate comparison of three controlled ovarian stimulation protocols for in vitro fertilization-embryo transfer in patients with diminished ovarian reserve after endometrioma cystectomy: a retrospective study.
Zhao F; Lan Y; Chen T; Xin Z; Liang Y; Li Y; Wang S; Zhang J; Yang X
J Ovarian Res; 2020 Feb; 13(1):23. PubMed ID: 32113477
[TBL] [Abstract][Full Text] [Related]
13. A simplified universal approach to COH protocol for IVF: ultrashort flare GnRH-agonist/GnRH-antagonist protocol with tailored mode and timing of final follicular maturation.
Orvieto R
J Ovarian Res; 2015 Nov; 8():69. PubMed ID: 26536862
[TBL] [Abstract][Full Text] [Related]
14. Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?
Wang YQ; Luo J; Xu WM; Xie QZ; Yan WJ; Wu GX; Yang J
J Ovarian Res; 2015 Sep; 8():63. PubMed ID: 26400057
[TBL] [Abstract][Full Text] [Related]
15. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin-releasing hormone agonist and antagonists, on follicular fluid stem cell factor and serum urocortin 1 levels on the day of oocyte retrieval.
Celik O; Celik E; Yilmaz E; Celik N; Turkcuoglu I; Ulas M; Kumbak B; Aktan E; Ozerol I
Arch Gynecol Obstet; 2013 Dec; 288(6):1417-22. PubMed ID: 23801011
[TBL] [Abstract][Full Text] [Related]
16. Does ovarian endometrioma affect the number of oocytes retrieved for in vitro fertilization?
Kiran H; Arikan DC; Kaplanoglu M; Bisak U; Cetin MT
Bratisl Lek Listy; 2012; 113(9):544-7. PubMed ID: 22979910
[TBL] [Abstract][Full Text] [Related]
17. Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin significantly improves live birth rate for women with diminished ovarian reserve.
Lin MH; Wu FS; Hwu YM; Lee RK; Li RS; Li SH
Reprod Biol Endocrinol; 2019 Jan; 17(1):7. PubMed ID: 30609935
[TBL] [Abstract][Full Text] [Related]
18. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
[TBL] [Abstract][Full Text] [Related]
19. Impact of varying stages of endometriosis on the outcome of in vitro fertilization-embryo transfer.
Pal L; Shifren JL; Isaacson KB; Chang Y; Leykin L; Toth TL
J Assist Reprod Genet; 1998 Jan; 15(1):27-31. PubMed ID: 9493063
[TBL] [Abstract][Full Text] [Related]
20. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
Albuquerque LE; Saconato H; Maciel MC
Cochrane Database Syst Rev; 2005 Jan; (1):CD002808. PubMed ID: 15674898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
